3//SEC Filing
CANAAN X L.P. 3
Accession 0001123292-19-000726
CIK 0001661059other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:06 PM ET
Size
25.9 KB
Accession
0001123292-19-000726
Insider Transaction Report
Form 3
NextCure, Inc.NXTC
CANAAN X L.P.
10% Owner
Holdings
Series A-3 Preferred Stock
→ Common Stock (729,599 underlying)Series A-2 Preferred Stock
→ Common Stock (743,110 underlying)Series B-1 Preferred Stock
→ Common Stock (285,867 underlying)Series A-1 Preferred Stock
→ Common Stock (445,866 underlying)
Canaan Partners X LLC
10% Owner
Holdings
Series A-2 Preferred Stock
→ Common Stock (743,110 underlying)Series B-1 Preferred Stock
→ Common Stock (285,867 underlying)Series A-1 Preferred Stock
→ Common Stock (445,866 underlying)Series A-3 Preferred Stock
→ Common Stock (729,599 underlying)
Footnotes (2)
- [F1]The reported securities are convertible into shares of Common Stock on a 1-for-8.0338 basis at the holder's election and will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering, and have no expiration date.
- [F2]The reported securities are held directly by Canaan X L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners X LLC ("Canaan X"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan X, collectively. Canaan X disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001619859
Filing Metadata
- Form type
- 3
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 8:06 PM ET
- Size
- 25.9 KB